Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

August 25, 2009

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Cervical AdenocarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedStage IA2 Cervical Cancer AJCC v6 and v7Stage IB1 Cervical Cancer AJCC v6 and v7
Interventions
PROCEDURE

Lymph Node Mapping

Undergo lymphatic mapping with sentinel lymph node biopsy

OTHER

Quality-of-Life Assessment

Ancillary studies

PROCEDURE

Salpingo-Oophorectomy

Undergo hysterectomy with or without salpingo-oophorectomy

PROCEDURE

Sentinel Lymph Node Biopsy

Undergo lymphatic mapping with sentinel lymph node biopsy

PROCEDURE

Therapeutic Conventional Surgery

Undergo hysterectomy with or without salpingo-oophorectomy

Trial Locations (20)

1181

Hospital Italiano of Buenos Aires, Buenos Aires

1407

Hospital Israelita Buenos Aires, Buenos Aires

1417

Instituto de Oncologia Angel H Roffo, Buenos Aires

3052

Royal Women's Hosptial, Victoria

10330

King Chulalongkorn University, Bangkok

11706

Northwell Health Imbert Cancer Center, Bay Shore

14080

Instituto Nacional De Cancerologia de Mexico, Mexico City

14784

Hosptial de Cancer de Barretos, Barretos

32207

Baptist MD Anderson Cancer Center, Jacksonville

68114

Nebraska Methodist Hospital, Omaha

77030

M D Anderson Cancer Center, Houston

77054

The Woman's Hospital of Texas, Houston

77058

MD Anderson League City, Nassau Bay

77094

MD Anderson in Katy, Houston

77384

MD Anderson in The Woodlands, The Woodlands

77478

MD Anderson in Sugar Land, Sugar Land

99999

Instituto Nacional De Cancerologia, Bogotá

08043

MD Anderson Cancer Center at Cooper-Voorhees, Voorhees Township

77026-1967

Lyndon Baines Johnson General Hospital, Houston

Lima 34

Instituto Nacional de Enfermedades Neoplasicas, Lima

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT01048853 - Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer | Biotech Hunter | Biotech Hunter